Table of Contents Table of Contents 3 List of Tables 4 List of Figures 4 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10 Venture Financing 10 NGM Biopharma Raises USD106 Million in Series E Financing 10 NGM Biopharmaceuticals Secures $36.8 Million Series D Financing 11 NGM Biopharma Raises USD20.7 Million in Series D Financing 12 NGM Biopharma Raises US$50 Million In Series C Venture Financing 13 Partnerships 14 NGM Biopharma Enters into R&D Agreement with Merck for Novel Biologic Therapeutics 14 MedImmune Enters Into Co-Development Agreement With NGM Biopharma 15 Daiichi Sankyo Enters Into Co-Development Agreement With NGM Biopharma For Diabetes Drugs 16 Licensing Agreements 17 Ablexis Enters into Licensing Agreement with NGM Biopharma 17 NGM Biopharma Enters Into Licensing Agreement With Janssen Pharma For New Diabetes Drugs 18 Equity Offering 19 NGM Biopharma Files Registration Statement to Raise up to USD75 Million IPO of Shares 19 NGM Biopharmaceuticals Inc - Key Competitors 20 NGM Biopharmaceuticals Inc - Key Employees 21 NGM Biopharmaceuticals Inc - Locations And Subsidiaries 22 Head Office 22 Recent Developments 23 Corporate Communications 23 Oct 01, 2018: NGM Biopharmaceuticals names David J. Woodhouse as Chief Executive Officer and Aetna Wun Trombley as President and Chief Operating Officer 23 Appendix 25 Methodology 25 About GlobalData 25 Contact Us 25 Disclaimer 25

List of Tables NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 NGM Biopharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9 NGM Biopharma Raises USD106 Million in Series E Financing 10 NGM Biopharmaceuticals Secures $36.8 Million Series D Financing 11 NGM Biopharma Raises USD20.7 Million in Series D Financing 12 NGM Biopharma Raises US$50 Million In Series C Venture Financing 13 NGM Biopharma Enters into R&D Agreement with Merck for Novel Biologic Therapeutics 14 MedImmune Enters Into Co-Development Agreement With NGM Biopharma 15 Daiichi Sankyo Enters Into Co-Development Agreement With NGM Biopharma For Diabetes Drugs 16 Ablexis Enters into Licensing Agreement with NGM Biopharma 17 NGM Biopharma Enters Into Licensing Agreement With Janssen Pharma For New Diabetes Drugs 18 NGM Biopharma Files Registration Statement to Raise up to USD75 Million IPO of Shares 19 NGM Biopharmaceuticals Inc, Key Competitors 20 NGM Biopharmaceuticals Inc, Key Employees 21List of Figures NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 NGM Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8